{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:14:49Z","timestamp":1792444489962,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Caffeine citrate is the gold-standard pharmacological treatment for apnea of prematurity, improving survival and long-term respiratory outcomes in preterm infants. Beyond its established central nervous system effects, emerging evidence suggests broader benefits in reducing extubation failure, lowering bronchopulmonary dysplasia rates, and decreasing the need for mechanical ventilation\u2014but its direct actions on the respiratory epithelium remain largely unknown. Caffeine is a methylxanthine with multiple molecular targets, including adenosine receptor antagonism, phosphodiesterase inhibition, and stimulation of calcium (Ca\u00b2\u207a) release from intracellular stores\u2014mechanisms also linked to the regulation of ciliary beat frequency (CBF), a critical determinant of mucociliary clearance. Since impaired CBF is a hallmark of several chronic airway diseases, understanding whether caffeine citrate can directly modulate this function could broaden its therapeutic relevance. We hypothesized that caffeine citrate directly enhances CBF in human respiratory epithelial cells (hRECs), thereby supporting airway defense mechanisms in health and disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CBF was quantified by high-speed video microscopy in hRECs derived from healthy donors and individuals with cystic fibrosis (CF) cultured under air\u2013liquid interface conditions. Caffeine citrate significantly increased CBF above baseline (CBF\n                      <jats:sub>b<\/jats:sub>\n                      ) in both healthy and CF-derived cells, indicating a robust and reproducible stimulatory effect. Mechanistic experiments identified ryanodine receptor (RYR)\u2013mediated Ca\u00b2\u207a efflux from intracellular stores as the key pathway, as pharmacological blockade of RYR abolished the caffeine-induced CBF enhancement.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study reveals a novel pharmacological effect of caffeine citrate\u2014direct stimulation of CBF in primary hRECs through RYR-dependent Ca\u00b2\u207a signaling. By improving mucociliary clearance, caffeine citrate may offer peripheral airway benefits in addition to its central actions for apnea prevention. Given its favorable pharmacokinetic profile, long half-life, and good tolerability compared to other methylxanthines, caffeine citrate warrants further evaluation as a dual-action therapy for respiratory diseases with compromised clearance, including CF and bronchopulmonary dysplasia. These findings expand the mechanistic understanding of caffeine\u2019s actions and highlight new translational opportunities in respiratory care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40348-026-00239-y","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:32:04Z","timestamp":1778567524000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Caffeine citrate increases ciliary beat frequency in human respiratory epithelial cells"],"prefix":"10.1186","volume":"13","author":[{"given":"Sandra","family":"Cindri\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bodenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Hjeij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki Tomas","family":"Loges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Edelbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Pennekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Rieger-Fackeldey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-6765","authenticated-orcid":false,"given":"Heymut","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"239_CR1","first-page":"545","volume":"4","author":"ROBERTS CL","year":"1954","unstructured":"ROBERTS CL (1954) Intravenous caffeine in prevention of neonatal asphyxia and narcosis. Obstet Gynecol 4:545\u2013547","journal-title":"Obstet Gynecol"},{"key":"239_CR2","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1592\/phco.20.7.644.35167","volume":"20","author":"A Erenberg","year":"2000","unstructured":"Erenberg A, Leff RD, Haack DG et al (2000) Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy 20:644\u2013652. https:\/\/doi.org\/10.1592\/phco.20.7.644.35167","journal-title":"Pharmacotherapy"},{"key":"239_CR3","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jpeds.2016.04.060","volume":"177","author":"K Alansari","year":"2016","unstructured":"Alansari K, Toaimah FH, Khalafalla H et al (2016) Caffeine for the Treatment of Apnea in Bronchiolitis: A Randomized Trial. J Pediatr 177:204\u2013211e3. https:\/\/doi.org\/10.1016\/j.jpeds.2016.04.060","journal-title":"J Pediatr"},{"key":"239_CR4","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/archdischild-2015-309396","volume":"101","author":"A Bel\u00e9n Rivas","year":"2016","unstructured":"Bel\u00e9n Rivas A, Arruza L, Pacheco E et al (2016) Adverse drug reactions in neonates: a prospective study. Arch Dis Child 101:371\u2013376. https:\/\/doi.org\/10.1136\/archdischild-2015-309396","journal-title":"Arch Dis Child"},{"key":"239_CR5","doi-asserted-by":"publisher","unstructured":"Hand I, Zaghloul N, Barash L et al (2016) Timing of Caffeine Therapy and Neonatal Outcomes in Preterm Infants: A Retrospective Study. Int J Pediatr 2016:9478204. https:\/\/doi.org\/10.1155\/2016\/9478204","DOI":"10.1155\/2016\/9478204"},{"key":"239_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1055\/s-0034-1543981","volume":"32","author":"AC Katheria","year":"2015","unstructured":"Katheria AC, Sauberan JB, Akotia D et al (2015) A Pilot Randomized Controlled Trial of Early versus Routine Caffeine in Extremely Premature Infants. Am J Perinatol 32:879\u2013886. https:\/\/doi.org\/10.1055\/s-0034-1543981","journal-title":"Am J Perinatol"},{"key":"239_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000442813","volume":"109","author":"G Lista","year":"2016","unstructured":"Lista G, Fabbri L, Polackova R et al (2016) The Real-World Routine Use of Caffeine Citrate in Preterm Infants: A European Postauthorization Safety Study. Neonatology 109:221\u2013227. https:\/\/doi.org\/10.1159\/000442813","journal-title":"Neonatology"},{"key":"239_CR8","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00431-015-2494-8","volume":"174","author":"S Mohammed","year":"2015","unstructured":"Mohammed S, Nour I, Shabaan AE et al (2015) High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial. Eur J Pediatr 174:949\u2013956. https:\/\/doi.org\/10.1007\/s00431-015-2494-8","journal-title":"Eur J Pediatr"},{"key":"239_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40360-016-0065-x","volume":"17","author":"T Yu","year":"2016","unstructured":"Yu T, Balch AH, Ward RM et al (2016) Incorporating pharmacodynamic considerations into caffeine therapeutic drug monitoring in preterm neonates. BMC Pharmacol Toxicol 17:22. https:\/\/doi.org\/10.1186\/s40360-016-0065-x","journal-title":"BMC Pharmacol Toxicol"},{"key":"239_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/pr.2015.72","volume":"78","author":"C McPherson","year":"2015","unstructured":"McPherson C, Neil JJ, Tjoeng TH et al (2015) A pilot randomized trial of high-dose caffeine therapy in preterm infants. Pediatr Res 78:198\u2013204. https:\/\/doi.org\/10.1038\/pr.2015.72","journal-title":"Pediatr Res"},{"key":"239_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2016.01.022","volume":"112","author":"A O\u00f1atibia-Astibia","year":"2016","unstructured":"O\u00f1atibia-Astibia A, Mart\u00ednez-Pinilla E, Franco R (2016) The potential of methylxanthine-based therapies in pediatric respiratory tract diseases. Respir Med 112:1\u20139. https:\/\/doi.org\/10.1016\/j.rmed.2016.01.022","journal-title":"Respir Med"},{"key":"239_CR12","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1242\/jeb.02377","volume":"209","author":"OM Woodward","year":"2006","unstructured":"Woodward OM, Willows AOD (2006) Nervous control of ciliary beating by Cl(-), Ca(2+) and calmodulin in Tritonia diomedea. J Exp Biol 209:2765\u20132773. https:\/\/doi.org\/10.1242\/jeb.02377","journal-title":"J Exp Biol"},{"key":"239_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev.physiol.69.040705.141253","volume":"69","author":"M Salathe","year":"2007","unstructured":"Salathe M (2007) Regulation of mammalian ciliary beating. Annu Rev Physiol 69:401\u2013422. https:\/\/doi.org\/10.1146\/annurev.physiol.69.040705.141253","journal-title":"Annu Rev Physiol"},{"key":"239_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrd3955","volume":"12","author":"J-F Chen","year":"2013","unstructured":"Chen J-F, Eltzschig HK, Fredholm BB (2013) Adenosine receptors as drug targets\u2013what are the challenges? Nat Rev Drug Discov 12:265\u2013286. https:\/\/doi.org\/10.1038\/nrd3955","journal-title":"Nat Rev Drug Discov"},{"key":"239_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/thorax.57.4.361","volume":"57","author":"C Bruce","year":"2002","unstructured":"Bruce C, Yates DH, Thomas PS (2002) Caffeine decreases exhaled nitric oxide. Thorax 57:361\u2013363. https:\/\/doi.org\/10.1136\/thorax.57.4.361","journal-title":"Thorax"},{"key":"239_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/01.cir.102.3.285","volume":"102","author":"K Varani","year":"2000","unstructured":"Varani K, Portaluppi F, Gessi S et al (2000) Dose and time effects of caffeine intake on human platelet adenosine A(2A) receptors: functional and biochemical aspects. Circulation 102:285\u2013289. https:\/\/doi.org\/10.1161\/01.cir.102.3.285","journal-title":"Circulation"},{"key":"239_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1085\/jgp.20028519","volume":"119","author":"O Zagoory","year":"2002","unstructured":"Zagoory O, Braiman A, Priel Z (2002) The mechanism of ciliary stimulation by acetylcholine: roles of calcium, PKA, and PKG. J Gen Physiol 119:329\u2013339. https:\/\/doi.org\/10.1085\/jgp.20028519","journal-title":"J Gen Physiol"},{"key":"239_CR18","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/nprot.2006.430","volume":"1","author":"N Rajan","year":"2006","unstructured":"Rajan N, Habermehl J, Cot\u00e9 M-F et al (2006) Preparation of ready-to-use, storable and reconstituted type I collagen from rat tail tendon for tissue engineering applications. Nat Protoc 1:2753\u20132758. https:\/\/doi.org\/10.1038\/nprot.2006.430","journal-title":"Nat Protoc"},{"key":"239_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1365-2818.2003.01209.x","volume":"211","author":"JH Sisson","year":"2003","unstructured":"Sisson JH, Stoner JA, Ammons BA et al (2003) All-digital image capture and whole-field analysis of ciliary beat frequency. J Microsc 211:103\u2013111. https:\/\/doi.org\/10.1046\/j.1365-2818.2003.01209.x","journal-title":"J Microsc"},{"key":"239_CR20","doi-asserted-by":"publisher","first-page":"13810","DOI":"10.1074\/jbc.M006104200","volume":"276","author":"F Zhao","year":"2001","unstructured":"Zhao F, Li P, Chen SR et al (2001) Dantrolene inhibition of ryanodine receptor Ca2\u2009+\u2009release channels. Molecular mechanism and isoform selectivity. J Biol Chem 276:13810\u201313816. https:\/\/doi.org\/10.1074\/jbc.M006104200","journal-title":"J Biol Chem"},{"key":"239_CR21","doi-asserted-by":"publisher","unstructured":"Sharma M, Akangire G, Hillman NH et al (2025) Defining endotypes of bronchopulmonary dysplasia in preterm infants to improve precision-based therapies. JCI Insight 10. https:\/\/doi.org\/10.1172\/jci.insight.193975","DOI":"10.1172\/jci.insight.193975"},{"key":"239_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.resp.2008.05.010","volume":"163","author":"A Braiman","year":"2008","unstructured":"Braiman A, Priel Z (2008) Efficient mucociliary transport relies on efficient regulation of ciliary beating. Respir Physiol Neurobiol 163:202\u2013207. https:\/\/doi.org\/10.1016\/j.resp.2008.05.010","journal-title":"Respir Physiol Neurobiol"},{"key":"239_CR23","doi-asserted-by":"publisher","first-page":"681842","DOI":"10.3389\/fphar.2021.681842","volume":"12","author":"J-Y Long","year":"2021","unstructured":"Long J-Y, Guo H-L, He X et al (2021) Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors. Front Pharmacol 12:681842. https:\/\/doi.org\/10.3389\/fphar.2021.681842","journal-title":"Front Pharmacol"},{"key":"239_CR24","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1164\/rccm.200811-1731OC","volume":"181","author":"JK Marthin","year":"2010","unstructured":"Marthin JK, Petersen N, Skovgaard LT et al (2010) Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study. Am J Respir Crit Care Med 181:1262\u20131268. https:\/\/doi.org\/10.1164\/rccm.200811-1731OC","journal-title":"Am J Respir Crit Care Med"},{"key":"239_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/cpf.12085","volume":"34","author":"M Munkholm","year":"2014","unstructured":"Munkholm M, Mortensen J (2014) Mucociliary clearance: pathophysiological aspects. Clin Physiol Funct Imaging 34:171\u2013177. https:\/\/doi.org\/10.1111\/cpf.12085","journal-title":"Clin Physiol Funct Imaging"},{"key":"239_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41572-020-0209-6","volume":"6","author":"J Wallmeier","year":"2020","unstructured":"Wallmeier J, Nielsen KG, Kuehni CE et al (2020) Motile ciliopathies. Nat Rev Dis Primers 6:77. https:\/\/doi.org\/10.1038\/s41572-020-0209-6","journal-title":"Nat Rev Dis Primers"},{"key":"239_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1891\/0730-0832.19.8.33","volume":"19","author":"BA Gannon","year":"2000","unstructured":"Gannon BA (2000) Theophylline or caffeine: which is best for apnea of prematurity? Neonatal Netw 19:33\u201336. https:\/\/doi.org\/10.1891\/0730-0832.19.8.33","journal-title":"Neonatal Netw"}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-026-00239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40348-026-00239-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-026-00239-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:32:08Z","timestamp":1778567528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40348-026-00239-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["239"],"URL":"https:\/\/doi.org\/10.1186\/s40348-026-00239-y","relation":{},"ISSN":["2194-7791"],"issn-type":[{"value":"2194-7791","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Published research complied with the guidelines for human studies and was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The study was approved by the Ethics Committee of the Westphalian Wilhelms University of Muenster (2013-512-f-S). Written informed consent to participate in this study was obtained from each subject involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}